Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.4.3 and the previous Revision: v3.4.2 label has been removed.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check61 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check76 days agoChange DetectedChanged the label for the update timestamp from 'Last Update Posted (Estimated)' to 'Last Update Posted' on the study record. This alters how update times are displayed but does not affect the underlying study data or eligibility criteria.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.